Files

Download

Download Full Text (462 KB)

Presentation date

Summer 8-12-2021

College, Institute, or Department

Pediatrics

Faculty Mentor

Dr. Jean Ballweg

Abstract

Multisystem Inflammatory Syndrome in Children (MIS-C) is a condition characterized by severe organ system inflammation and shock, presenting approximately 4-6 weeks after infection with the virus SARS-CoV-2. This disease was first identified in April 2020 and appears to be one of the most severe forms of disease associated with COVID-19 in children. A single-center retrospective study was performed on a cohort of patients diagnosed with MIS-C at Children's Hospital and Medical Center in Omaha. A variety of data--including patient demographics, hospital course, treatments, and long-term cardiac outcomes--were analyzed to better understand MIS-C as an emerging disease.

Keywords

Pediatrics, Multisystem Inflammatory Syndrome, MIS-C, COVID-19, SARS-CoV-2, Cardiology

Multisystem Inflammatory Syndrome in Children - Characteristics, Therapies, and Outcomes

Share

COinS